Gross margin moved 5525 bp higher
Gross margin changed +5525 basis points from the comparable as-filed period.
29.77%→85.01%2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →SNDK financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Revenue increased 377.9%
Revenue changed +377.9% from the comparable as-filed period.
$2.3B→$11.0B2 prior comparisons
Operating margin moved 7197 bp higher
Operating margin changed +7197 basis points from the comparable as-filed period.
7.63%→79.59%2 prior comparisons
Cash & equivalents increased 256.2%
Cash & equivalents changed +256.2% from the comparable as-filed period.
$1.4B→$5.1B2 prior comparisons
Working capital increased 171.1%
Working capital changed +171.1% from the comparable as-filed period.
$3.5B→$9.4B2 prior comparisons
Inventory increased 58.2%
Inventory changed +58.2% from the comparable as-filed period.
$1.9B→$3.0B2 prior comparisons
Current assets increased 208.0%
Current assets changed +208.0% from the comparable as-filed period.
$5.0B→$15.4B2 prior comparisons
Trade receivables increased 452.0%
Trade receivables changed +452.0% from the comparable as-filed period.
$1.2B→$6.6B2 prior comparisons
Free-cash-flow proxy changed across a low base
Free-cash-flow proxy changed +1340.4% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a low base.
$438.0M→$6.3B2 prior comparisons
Inventory / revenue moved 5528 bp lower
Inventory / revenue changed -5528 basis points from the comparable as-filed period.
82.63%→27.34%2 prior comparisons
Operating cash flow changed across a low base
Operating cash flow changed +1203.9% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a low base.
$488.0M→$6.4B2 prior comparisons
Current liabilities increased 292.5%
Current liabilities changed +292.5% from the comparable as-filed period.
$1.5B→$6.0B2 prior comparisons
Total assets increased 102.3%
Total assets changed +102.3% from the comparable as-filed period.
$12.7B→$25.8B2 prior comparisons
Operating income changed across a low base
Operating income changed +4888.6% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a low base.
$176.0M→$8.8B2 prior comparisons
Operating margin moved 18007 bp higher
Operating margin changed +18007 basis points from the comparable as-filed period.
-110.97%→69.09%0 prior comparisons
Gross margin moved 5582 bp higher
Gross margin changed +5582 basis points from the comparable as-filed period.
22.54%→78.35%0 prior comparisons
Revenue increased 251.0%
Revenue changed +251.0% from the comparable as-filed period.
$1.7B→$6.0B0 prior comparisons
Cash & equivalents increased 147.8%
Cash & equivalents changed +147.8% from the comparable as-filed period.
$1.5B→$3.7B1 prior comparisons
Trade receivables increased 178.4%
Trade receivables changed +178.4% from the comparable as-filed period.
$979.0M→$2.7B1 prior comparisons
Working capital increased 95.2%
Working capital changed +95.2% from the comparable as-filed period.
$3.7B→$7.3B1 prior comparisons
Current assets increased 80.1%
Current assets changed +80.1% from the comparable as-filed period.
$5.1B→$9.2B1 prior comparisons
Total assets increased 31.8%
Total assets changed +31.8% from the comparable as-filed period.
$13.0B→$17.1B1 prior comparisons
Gross debt decreased 100.0%
Gross debt changed -100.0% from the comparable as-filed period.
$1.9B→$00 prior comparisons
Noncurrent long-term debt decreased 100.0%
Noncurrent long-term debt changed -100.0% from the comparable as-filed period.
$1.9B→$00 prior comparisons
Reported total debt decreased 100.0%
Reported total debt changed -100.0% from the comparable as-filed period.
$1.9B→$00 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.